Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease

ABSTRACT Background Neurofilament light chain protein (NfL) is a promising biomarker of neurodegeneration. Objectives To determine whether plasma and CSF NfL (1) associate with motor or cognitive status in Parkinson's disease (PD) and (2) predict future motor or cognitive decline in PD. Methods...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Movement disorders Ročník 36; číslo 12; s. 2945 - 2950
Hlavní autoři:	Aamodt, Whitley W., Waligorska, Teresa, Shen, Junchao, Tropea, Thomas F., Siderowf, Andrew, Weintraub, Daniel, Grossman, Murray, Irwin, David, Wolk, David A., Xie, Sharon X., Trojanowski, John Q., Shaw, Leslie M., Chen‐Plotkin, Alice S.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Hoboken, USA John Wiley & Sons, Inc 01.12.2021 Wiley Subscription Services, Inc
Témata:	Biomarkers Biomarkers - cerebrospinal fluid Cerebrospinal fluid Cognition Cognitive ability Cognitive Dysfunction - cerebrospinal fluid Cognitive Dysfunction - diagnosis Cognitive Dysfunction - etiology Cross-Sectional Studies Dementia Dementia disorders Disease Progression Humans Intermediate Filaments - metabolism Medical prognosis Movement disorders Neurodegeneration Neurodegenerative diseases neurofilament light chain protein NfL Parkinson Disease - complications Parkinson Disease - diagnosis Parkinson's disease Plasma prognosis Regression analysis Parkinson's disease neurofilament light chain protein NfL prognosis biomarkers
ISSN:	0885-3185, 1531-8257, 1531-8257
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!